For example, no mutations in any of the three PHD genes were found among 82 patients with hereditary paragangliomas [109] and only a single sample with a mutation in the PHD2 gene was identified during the analysis of 72 pheochromocytomas and 14 paragangliomas [79]. This evidence concerns the gene EGLN1 and paraganglioma.